■ 学術雑誌
|
原著
|
|
1.
|
Otani T, Suzuki M, Takakura H, Hanaoka H.：
Synthesis and biological evaluation of EGFR binding peptides for near-infrared photoimmunotherapy.
Bioorganic & medicinal chemistry
105
：117717
, 2024
|
|
2.
|
Suzuki M, Kobayashi H, Hara D, Hanaoka H.：
Elimination of radiation-induced senescent cancer cells and stromal cells in vitro by near-infrared photoimmunotherapy.
Cancer medicine
13
(12)
：e7381
, 2024
|
|
3.
|
Suzuki M, Kobayashi H, Hanaoka H.：
Evaluation of a Novel Lateral Emitting Laser Fiber for Near-Infrared Photoimmunotherapy.
Cancers
16
(14)
：2558
, 2024
|
|
4.
|
Kondo N, Yonezawa M, Hirano F, Temma T.：
Comparison of Exendin-4 and Its Single Amino Acid Substitutions as Parent Peptides for GLP-1 Receptor Imaging Probes.
Molecules
30
(5)
：1011
, 2025
|
|
5.
|
Suzuki M, Kobayashi H, Hanaoka H.：
Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor.
Translational oncology
50
：102132
, 2024
|
|
総説及び解説
|
|
1.
|
Nakamoto Y, Inui Y, Hotta M, Wakabayashi H, Hanaoka H.：
Recent advancements in new tracers from first-in-human studies.
Annals of nuclear medicine
38
(11)
：877
-883
, 2024
|
|
2.
|
Maskur; Wongso, H; Humani, TS; Effendi, N; Palangka, CRAP; Pujiyanto, A; Setiawan, H; Juliyanto, S; Ridwan, M; Ritawidya, R：
Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177-radiopharmaceuticals based on antibodies.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
100
：106104
, 2024
|
|
3.
|
Achmad A, Hanaoka H, Holik HA, Endo K, Tsushima Y, Kartamihardja AHS.：
LAT1-specific PET radiotracers: Development and clinical experiences of a new class of cancer-specific radiopharmaceuticals.
Theranostics
15
(5)
：1864
-1878
, 2025
|
|
その他
|
|
1.
|
大谷 拓也, 花岡 宏史：
EGFR結合ペプチドの光免疫療法薬としての利用.
細胞
56
(7)
：536
-538
, 2024
|
|
■ 学会発表
|
国際学会及び海外の学会
|
|
1.
|
◎Citra Rezza Aurora Putri Palangka, Hirofumi Hanaoka：
Development of Clinically Applicable Radioimmunotherapy for Triple-Negative Breast Cancer.
The 12th China-Japan-Korea Association of Radiopharmaceutical Sciences (CJKARS2024),
金沢市,
2024/09
|
|
全国規模の学会
|
|
1.
|
◎大谷 拓也, 花岡 宏史：
HER2結合ペプチドを基盤とする新規光免疫療法薬の創製研究.
日本薬学会第145年会,
福岡市,
2025/03
|
|
その他
|
|
1.
|
花岡 宏史：
光免疫療法の基礎と今後の展望.
第６回 日本核医学会近畿支部会,
大阪府,
2024/07
|
|
2.
|
花岡 宏史：
光免疫療法に資するデバイスの開発.
第一回光免疫療法研究会,
東京都,
2024/12
|
|
